Introduction And Epidemiology

• Constitutes acute self-limited febrile illness.
• Primarily affects children under five years of age.
• Represents leading cause of acquired pediatric heart disease in developed nations.
• Carries twenty-five percent risk of coronary artery dilation or aneurysms if left untreated.
• Demonstrates highest incidence in northeast Asian countries including Japan, South Korea, China, Taiwan.
• Pathogenesis remains completely unknown.

Diagnosis And Clinical Features

• Remains purely clinical diagnosis lacking pathognomonic diagnostic test.
• Standard diagnosis requires four days of fever.
• Experienced clinicians may establish diagnosis after three days of fever.
• Early diagnosis within ten days of fever onset remains crucial to prevent coronary dilation.

Complete Diagnostic Criteria

• Requires four out of five principal clinical features.
• Polymorphous rash.
• Bilateral nonexudative conjunctival injection.
• Extremity changes including erythema, swelling, or subsequent peeling.
• Oropharyngeal changes including strawberry tongue, erythematous lips.
• Cervical lymphadenopathy, usually unilateral, measuring greater than 1.5 centimeters.

Incomplete Kawasaki Disease

• Features prolonged unexplained fever.
• Manifests fewer than four principal clinical features.
• Diagnosed via compatible laboratory or echocardiographic findings.

Kawasaki Disease Shock Syndrome

• Constitutes rare, severe illness form.
• Presents with vasodilatory shock, severe hypotension, poor systemic perfusion.
• Frequently presents with elevated C-reactive protein, hypoalbuminemia, severe thrombocytopenia.
• Carries significantly increased risk for intravenous immunoglobulin resistance and coronary abnormalities.
• Demands immediate intensification of initial therapy.

Differentiating Multisystem Inflammatory Syndrome In Children

• Presents as differential diagnosis since emergence of SARS-CoV-2.
• Features prominent gastrointestinal symptoms including abdominal pain, vomiting, diarrhea.
• Frequently involves prominent headache.
• Laboratory profile reveals marked thrombocytopenia, lymphopenia, elevated troponin, elevated brain natriuretic peptide.
• Cardiac evaluation demonstrates decreased left ventricular systolic function, pericardial effusion.
• Machine learning algorithms assist in clinical differentiation.

High-Risk Criteria For Coronary Artery Aneurysms

• Identifies candidates for intensified primary anti-inflammatory therapy.
• Age under six months constitutes universally accepted high-risk feature.
• Baseline echocardiogram demonstrating coronary artery Z score greater than or equal to 2.5 establishes high risk.
• North American risk score assigns points for age under six months, Asian race, Z score over 2, C-reactive protein over 13 mg/dL.
• Risk score of 3 or greater strongly predicts aneurysm development by 8 weeks.

Cardiac Imaging In Acute Phase

Echocardiography Standards

• Serves as primary, noninvasive imaging modality.
• Mandates highest-frequency transducer possible.
• Requires accurate patient weight and height for precise body surface area calculation.
• Centers must utilize consistent Z score equations sequentially to prevent risk classification errors.
• Baseline normal echocardiogram does not exclude future aneurysm development.
• Repeat imaging indicated before hospital discharge for high-risk patients.
• Myocardial dysfunction with reduced shortening fraction occurs in twenty percent of patients at diagnosis.

Quantitative Z-Score Classification

Acute Medical Management

Standard Initial Therapy

Intensification Therapy For High-Risk Patients

• Strongly indicated for baseline Z score 2.5 or greater.
• Strongly indicated for infants under six months of age.
• Goal involves reducing progressive coronary artery expansion.

Management Of Intravenous Immunoglobulin Resistance

• Defined strictly as persistent or recrudescent fever 36 hours post initial infusion completion.
• Carries profoundly increased risk for developing coronary artery aneurysms.

Additional Therapies For Refractory Disease

Antithrombotic And Anticoagulation Therapy

• Large aneurysms harbor severe risk for luminal thrombosis.
• Requires dual approach combining antiplatelet agents and systemic anticoagulation.
• Dual antiplatelet therapy considered for any aneurysm reaching Z score 5 or greater.
• Clopidogrel (1 mg/kg/day) serves as primary alternative for aspirin allergy.
• Warfarin therapy historically standard but requires intensive monitoring.
• Low molecular weight heparin historically standard but mandates painful twice-daily pediatric injections.
• Direct oral anticoagulants provide highly attractive, targeted alternative.
• Apixaban demonstrated profound safety lacking thromboembolic events in pediatric cardiac disease trial.
• Edoxaban demonstrated equivalent efficacy to standard anticoagulants.
• Reversal agents including prothrombin concentrates and andexanet alfa available for massive bleeding complications.

Management Of Acute Myocardial Infarction

• Risk peaks dramatically during first 2 to 3 months following illness onset.
• Lifetime ongoing ischemia risk persists indefinitely for patients harboring large or giant aneurysms.
• Presents atypically compared to adult atherosclerotic disease.
• Infants manifest nonspecific pain, unexplained crying, severe restlessness, unusual pallor, profuse sweating.
• Older children exhibit chest pain, breathlessness, unexplained vomiting, focal skin discoloration.
• Requires immediate coordinated response from multidisciplinary cardiovascular heart team.
• ST-segment elevation myocardial infarction mandates percutaneous coronary intervention within 90 minutes.
• Medical thrombolysis utilizing tissue-type plasminogen activator indicated if patient size precludes catheterization.
• Post-infarction medical therapy integrates aspirin, beta-blockers, statins, angiotensin-converting enzyme inhibitors.

Long-Term Management And Risk Stratification

• Long-term trajectory strictly determined by maximal coronary artery Z score achieved during acute phase.
• Small aneurysms exhibit near-universal normalization of internal lumen diameter over time.
• Complete regression of small aneurysms carries near-zero long-term risk of adverse cardiac events.
• Stable regressed aneurysms warrant decreased frequency of surveillance visits.

Risk Level Classification And Follow-Up Protocol

Advanced Surveillance Imaging

• Transthoracic echocardiogram serves as standard primary surveillance tool.
• Demonstrates lower sensitivity for detecting distal coronary aneurysms compared to advanced modalities.

Computed Tomography Angiography

• Visualizes entire coronary tree comprehensively.
• Reliably assesses aneurysm morphology, strictures, thrombosis, and stenosis exceeding fifty percent.
• Possesses superior spatial resolution compared to magnetic resonance imaging for evaluating distal lesions.
• Radiation exposure successfully mitigated by modern dual-source technology limiting dose below 1 mSv.
• Detects profound late-stage vessel calcifications occurring decades following acute illness.
• Serves as recommended 1-year baseline evaluation for patients with large or giant aneurysms.
• Computed tomography-derived fractional flow reserve models hemodynamic flow to evaluate severity of stenotic lesions.

Cardiovascular Magnetic Resonance Imaging

• Evaluates complete ventricular function and tissue characteristics entirely without radiation.
• Ferumoxytol-enhanced angiography facilitates excellent visualization of coronary walls.
• Identifies critical myocardial fibrosis utilizing T1 mapping and late gadolinium enhancement.
• Detects myocardial inflammation utilizing T2 mapping.
• Safely identifies inducible perfusion defects utilizing regadenoson or adenosine pharmacologic stress testing.

Invasive Coronary Angiography

• Delineates complex coronary architecture, discrete stenoses, collateral vessel formation.
• Strictly reserved for percutaneous revascularization planning.
• Utilizes fractional flow reserve assessing pressure differences directly across stenotic lesions.
• Incorporates intravascular ultrasound offering superior spatial resolution of wall morphology and plaque composition.
• Incorporates optical coherence tomography visualizing micro-structural changes within coronary wall.

Assessment Of Inducible Ischemia

• Mandated for patients harboring Z scores of 10 or greater due to exceptional risk.
• High cumulative incidence of severe luminal narrowing necessitates scheduled surveillance regardless of symptomatic status.
• Exercise stress echocardiography serves as preferred, radiation-free screening tool for children over 7 years.
• Dobutamine pharmacologic stress echocardiography successfully identifies wall motion abnormalities in infants unable to exercise.

Health Care Transition

• Structured, protocol-driven health care transition remains absolutely paramount.
• Medical teams must aggressively plan seamless transfer into adult cardiology networks.
• Employs Six Core Elements framework encompassing structured planning, structured transfer, adult care integration.
• Adult cardiologists must manage long-term consequences including acute coronary syndrome, progressive heart failure, arrhythmias.
• Pregnant women with established giant aneurysms receiving systemic anticoagulation require immediate high-risk obstetrics referral coupled with intensive cardiology consultation.